PPHM 1501- An open-label, randomized, phase II trial of durvalumab (MEDI4736) with or without bavituximab in patients with previously treated metastatic non-small cell lung cancer (NSCLC): Safety report on first 18 patients.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e14537-e14537
Author(s):  
Ronald B. Natale ◽  
David R. Spigel ◽  
Rachel E. Sanborn ◽  
Alberto Chiappori ◽  
Suresh S. Ramalingam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Safety Report ◽  
Randomized Phase Ii ◽  
Previously Treated

scholarly journals Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

2004 ◽  
Vol 10 (15) ◽  
pp. 5022-5026 ◽  
Author(s):  
Martin J. Edelman ◽  
Joseph I. Clark ◽  
Kari Chansky ◽  
Kathy Albain ◽  
Nirmala Bhoopalam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Sequential Chemotherapy ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document